Cargando…
Effect of early dose increase of evocalcet for intractable hypercalcemia caused by parathyroid carcinoma
SUMMARY: Hypercalcemia due to parathyroid carcinoma (PC) is safely and quickly controlled with rapidly increasing evocalcet doses. Most parathyroid carcinomas are detected because of hypercalcemia due to primary hyperparathyroidism (PHPT). Hypercalcemia becomes more severe in patients with PC than t...
Autores principales: | Morishita, Azusa, Hozumi, Yasuo, Ishii, Hiroaki, Hokazono, Yukio, Manuel Yosei Kikuchi, Clovis, Shimasaki, Megumi, Itaya, Mikiko, Oura, Masaharu, Kuriki, Ken, Hishida, Akira, Seki, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875064/ https://www.ncbi.nlm.nih.gov/pubmed/36602916 http://dx.doi.org/10.1530/EDM-22-0269 |
Ejemplares similares
-
Successful use of cinacalcet to treat parathyroid-related hypercalcemia in two pediatric patients
por: Mogas, E, et al.
Publicado: (2018) -
Hypercalcemia of malignancy treated with cinacalcet
por: Asonitis, Nikolaos, et al.
Publicado: (2017) -
Palliative treatment of uncontrollable hypercalcemia due to parathyrotoxicosis: denosumab as rescue therapy
por: Jumpertz von Schwartzenberg, Reiner, et al.
Publicado: (2015) -
Parathyroid carcinoma with pancreatitis causing hypercalcaemic emergency treated with extracorporeal membrane oxygenation-assisted parathyroid resection
por: Toyoda, Madoka, et al.
Publicado: (2022) -
The use of cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma
por: Nadarasa, K, et al.
Publicado: (2014)